Medspira, and Mayo Clinic have entered into an agreement to commercialize, manufacture and market several Mayo Clinic developed products and technologies invented by Mayo physicians and scientists. Mayo Clinic technologies included in the license agreement are two Radiology products currently available in the market, the Interactive Breath-Hold Control System and the BC-10 MRI Coils, and two technologies that Medspira will develop further, with the intent of making them commercially available in the next 12-24 months. "Medspira is honored to work with Mayo Clinic where research is a critical part of its commitment to excellence and interdependence in the three areas of research, education and patient care," said Tim Anderson Medspira CEO.
Commercially Available Technologies
The Breath Hold Interactive Breath-Hold Control System is a noninvasive device that enables patients to perform consistent, repeatable breath-holds during diagnostic imaging and image-guided interventional procedures. Respiratory motion and inconsistent patient breath-holds can prevent accurate needle biopsies of small masses in the lung and upper abdomen. Image-guided needle biopsies can be preformed on an outpatient basis, have less complications, are much less invasive to the patient, and are less costly than surgical biopsies. Breath Hold has FDA cleared (Class II, 513(g)) and CE marked (Class I).
Mayo Clinic's BC-10 MRI Coil is designed to allow acquisition of high resolution MRI images of the wrist at 1.5 and 3.0 Tesla. The BC-10's bird cage design provides a level of detail needed to diagnose many problems within the complicated structures of the wrist and hand. Products have FDA cleared (510(k) Class II) and CE marked (Class I).
Technologies Under Development: